Medical professionals highlight the critical need to actively manage bone thinning to protect people with Parkinson's from serious fractures

When managing Parkinson's, clinical focus usually goes straight to walking, balance, and tremor. However, a major review published in the journal Expert Opinion on Pharmacotherapy emphasizes that bone health deserves equal attention. Bone thinning, known as osteoporosis, is a major hidden complication that is far more common in people with Parkinson's than in the general public. Because the condition naturally increases the likelihood of falling, fragile bones create a perfect storm for severe fractures that can permanently reduce independence. The medical review breaks down exactly why bone density drops so sharply when living with Parkinson's. A primary factor is reduced physical activity. Bones need regular weight bearing pressure to stay thick and strong, so moving less naturally leads to bone loss. On top of that, many people experience low vitamin D levels, which are vital for bone repair. Even the treatment itself plays a role, as certain Parkinson's medications can cause elevated levels of an amino acid called homocysteine, which directly interferes with the quality and strength of the bone structure. Combined with frequent falls caused by balance difficulties and freezing of gait, the risk of a bone break becomes dangerously high. To combat this, the clinical review urges medical teams to take a much more proactive approach to screening and treatment. Doctors should regularly assess fracture risk, often using specialized screening tools and bone density scans to catch thinning before a break happens. Ensuring adequate intake of calcium and vitamin D is the baseline defense, but most people with bone loss will require specific medical treatments to truly safeguard their skeleton. The review highlights several highly effective, standard medical options available to doctors. Bisphosphonates are the most common first line treatments, working to slow down the cells that break down bone tissue. For individuals who cannot tolerate these, or who require a different approach, clinicians can use targeted biological therapies or medications that actively stimulate new bone formation. By identifying bone thinning early and using these standard medical therapies, clinicians can significantly lower the risk of fractures, protecting mobility and ensuring that a simple trip does not lead to a serious injury.